Key points are not available for this paper at this time.
Significant disparities in drug accessibility persist across the Asia-Pacific region. Achieving the WHO End Tuberculosis Strategy goals requires accelerating drug regulatory approvals, strengthening public-private collaboration, and sustained international support for resource-limited settings.
Pei et al. (Sun,) studied this question.